Invention Grant
- Patent Title: Intestinal alkaline phosphatase formulations
-
Application No.: US16982236Application Date: 2019-03-20
-
Publication No.: US11638699B2Publication Date: 2023-05-02
- Inventor: Andrew Bristol , Ray Stapleton , Michael Kaleko , Christian Furlan Freguia , Steven Hubert , Cristina Freire , James Gubbins
- Applicant: Theriva Biologics, Inc.
- Applicant Address: US MD Rockville
- Assignee: Theriva Biologics, Inc.
- Current Assignee: Theriva Biologics, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Morgan, Lewis & Bockius LLP
- International Application: PCT/US2019/023142 WO 20190320
- International Announcement: WO2019/183208 WO 20190926
- Main IPC: A61K9/28
- IPC: A61K9/28 ; A61K9/19 ; A61K9/20 ; A61K38/46 ; C12N9/16 ; C12N15/63 ; C12N15/52
Abstract:
The present invention provides for a formulation comprising an active alkaline phosphatase (AP)-based agent and an enteric agent, wherein the formulation is suitable for releasing a substantial amount of the active AP-based agent in the intestines.
Public/Granted literature
- US20210030686A1 INTESTINAL ALKALINE PHOSPHATASE FORMULATIONS Public/Granted day:2021-02-04
Information query
